Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1457)
ARTG (43)
Cancellation or suspension (26)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2025 (58)
2024 (1215)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (3)
2017 (44)
2015 (15)
2014 (6)
2013 (2)
2012 (7)
2011 (6)
2010 (1)
2009 (1)

Search

Sponsor content

1533 result(s) found, displaying 1471 to 1480

LATANOPROST GH latanoprost 50 micrograms/mL Eye drops, solution Cancelled under s30(1)(c) of the Act

5 February 2018

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
PIAX PLUS ASPIRIN 75/100 clopidogrel (as hydrogen sulfate) and aspirin 75 mg/100 mg uncoated tablet blister pack (219059)

27 October 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for PIAX PLUS ASPIRIN 75/100 clopidogrel (as hydrogen sulfate) and aspirin 75 mg/100 mg uncoated tablet blister pack.
CLOAP 75/100 clopidogrel (as hydrogen sulfate) and aspirin 75 mg/100 mg uncoated tablet blister pack (219058)

27 October 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CLOAP 75/100 clopidogrel (as hydrogen sulfate) and aspirin 75 mg/100 mg uncoated tablet blister pack.
ESOMEPRAZOLE MEDIS esomeprazole (as magnesium dihydrate) 40 mg enteric coated tablet blister pack (210847)

30 July 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ESOMEPRAZOLE MEDIS esomeprazole (as magnesium dihydrate) 40 mg enteric coated tablet blister pack.
ESOMEPRAZOLE MEDIS esomeprazole (as magnesium dihydrate) 20 mg enteric coated tablet blister pack (210848)

30 July 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for ESOMEPRAZOLE MEDIS esomeprazole (as magnesium dihydrate) 20 mg enteric coated tablet blister pack.
CAMDIS, AMLODIPINE/ATORVASTATIN-AS, AMLODIPINE/ATORVASTATIN-GX, AMLODIPINE/ATORVASTATIN-MEDIS, AMLODIPINE/ATORVASTATIN-ZP (Medis Pharma Pty Ltd)

12 July 2017

Prescription medicine registration

Active ingredients: amlodipine(as besilate); atorvastatin(as calcium).
GLIMEPIRIDE WATSON 2 glimepiride 2 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SIMVASTATIN-SPIRIT 20 simvastatin 20 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SIMVASTATIN-SPIRIT 40 simvastatin 40 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
SIMVASTATIN-SPIRIT 80 simvastatin 80 mg tablet blister pack Cancelled under s30(1)(c)

29 June 2017

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 144
Page 145
Page 146
Page 147
Current page 148
Page 149
Page 150
Page 151
Page 152
…
Next page
Last page

Is there anything wrong with this page?

Help us improve

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.